Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(-6.3%)
USD 1.19
(-6.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -334.46 Million USD | -1.82% |
| 2022 | -304.81 Million USD | -71.09% |
| 2021 | -178.16 Million USD | -70.68% |
| 2020 | -104.38 Million USD | -3.82% |
| 2019 | -100.54 Million USD | 0.44% |
| 2018 | -100.98 Million USD | -12.48% |
| 2017 | -89.78 Million USD | -26.02% |
| 2016 | -71.24 Million USD | -144.54% |
| 2015 | -29.13 Million USD | 53.65% |
| 2014 | -62.85 Million USD | 18.94% |
| 2013 | -77.54 Million USD | 17.8% |
| 2012 | -94.33 Million USD | 14.05% |
| 2011 | -109.75 Million USD | 21.73% |
| 2010 | -140.23 Million USD | -59.23% |
| 2009 | -88.07 Million USD | -96.55% |
| 2008 | -44.8 Million USD | -91.57% |
| 2007 | -23.39 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -81.43 Million USD | 5.73% |
| 2024 Q2 | -64.61 Million USD | -79.01% |
| 2023 Q2 | -73.17 Million USD | 19.81% |
| 2023 Q1 | -91.25 Million USD | -10.63% |
| 2023 Q4 | -86.38 Million USD | -4.72% |
| 2023 Q3 | -82.49 Million USD | -12.73% |
| 2023 FY | -310.36 Million USD | -1.82% |
| 2022 Q3 | -70.34 Million USD | -3.49% |
| 2022 Q2 | -67.96 Million USD | 13.51% |
| 2022 Q4 | -82.48 Million USD | -17.27% |
| 2022 FY | -304.81 Million USD | -71.09% |
| 2022 Q1 | -78.58 Million USD | -21.51% |
| 2021 FY | -178.16 Million USD | -70.68% |
| 2021 Q1 | -33.71 Million USD | -40.59% |
| 2021 Q2 | -37.57 Million USD | -11.46% |
| 2021 Q3 | -74.47 Million USD | -98.22% |
| 2021 Q4 | -64.67 Million USD | 13.16% |
| 2020 Q3 | -24.17 Million USD | -2.77% |
| 2020 Q2 | -23.52 Million USD | 28.08% |
| 2020 Q1 | -32.7 Million USD | -82.56% |
| 2020 FY | -104.38 Million USD | -3.82% |
| 2020 Q4 | -23.97 Million USD | 0.82% |
| 2019 FY | -100.54 Million USD | 0.44% |
| 2019 Q1 | -30.13 Million USD | 1.6% |
| 2019 Q2 | -24.38 Million USD | 19.09% |
| 2019 Q3 | -28.11 Million USD | -15.32% |
| 2019 Q4 | -17.91 Million USD | 36.27% |
| 2018 Q3 | -24.67 Million USD | -13.45% |
| 2018 Q1 | -23.94 Million USD | -16.66% |
| 2018 FY | -100.98 Million USD | -12.48% |
| 2018 Q4 | -30.62 Million USD | -24.13% |
| 2018 Q2 | -21.74 Million USD | 9.2% |
| 2017 Q1 | -23.29 Million USD | -30.35% |
| 2017 FY | -89.78 Million USD | -26.02% |
| 2017 Q4 | -20.52 Million USD | 4.82% |
| 2017 Q3 | -21.56 Million USD | 11.56% |
| 2017 Q2 | -24.38 Million USD | -4.67% |
| 2016 Q2 | -18.07 Million USD | 2.67% |
| 2016 Q3 | -16.73 Million USD | 7.39% |
| 2016 Q4 | -17.87 Million USD | -6.81% |
| 2016 FY | -71.24 Million USD | -144.54% |
| 2016 Q1 | -18.56 Million USD | -1648.12% |
| 2015 Q4 | -1.06 Million USD | -140.63% |
| 2015 Q1 | -19.32 Million USD | -8.01% |
| 2015 Q2 | -11.35 Million USD | 41.24% |
| 2015 Q3 | 2.61 Million USD | 123.01% |
| 2015 FY | -29.13 Million USD | 53.65% |
| 2014 Q3 | -8.41 Million USD | 54.03% |
| 2014 Q1 | -18.24 Million USD | -7.3% |
| 2014 FY | -62.85 Million USD | 18.94% |
| 2014 Q4 | -17.89 Million USD | -112.69% |
| 2014 Q2 | -18.3 Million USD | -0.31% |
| 2013 Q4 | -17 Million USD | 14.7% |
| 2013 Q3 | -19.93 Million USD | 0.31% |
| 2013 Q2 | -19.99 Million USD | 2.96% |
| 2013 Q1 | -20.6 Million USD | 5.01% |
| 2013 FY | -77.54 Million USD | 17.8% |
| 2012 Q1 | -27.51 Million USD | -21.25% |
| 2012 Q2 | -22.55 Million USD | 18.01% |
| 2012 Q4 | -21.69 Million USD | 3.92% |
| 2012 Q3 | -22.57 Million USD | -0.11% |
| 2012 FY | -94.33 Million USD | 14.05% |
| 2011 Q2 | -22.66 Million USD | 35.19% |
| 2011 Q1 | -34.96 Million USD | 4.43% |
| 2011 FY | -109.75 Million USD | 21.73% |
| 2011 Q4 | -22.68 Million USD | 22.92% |
| 2011 Q3 | -29.43 Million USD | -29.89% |
| 2010 Q3 | -40.69 Million USD | -24.55% |
| 2010 Q4 | -36.58 Million USD | 10.09% |
| 2010 Q1 | -30.27 Million USD | -7.84% |
| 2010 FY | -140.23 Million USD | -59.23% |
| 2010 Q2 | -32.67 Million USD | -7.93% |
| 2009 Q4 | -28.07 Million USD | -14.27% |
| 2009 FY | -88.07 Million USD | -96.55% |
| 2009 Q3 | -24.56 Million USD | 0.0% |
| 2008 FY | -44.8 Million USD | -91.57% |
| 2007 FY | -23.39 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -2228.995% |
| Cerus Corporation | -30.05 Million USD | -1012.924% |
| OrthoPediatrics Corp. | -25.76 Million USD | -1198.094% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -3049.009% |
| Talis Biomedical Corporation | -66.81 Million USD | -400.587% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -1833.782% |
| Inogen, Inc. | -109.38 Million USD | -205.768% |
| Spectral AI, Inc. | -12.98 Million USD | -2475.994% |
| Nano-X Imaging Ltd. | -62.58 Million USD | -434.386% |
| CVRx, Inc. | -43.1 Million USD | -675.972% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -9380.357% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -2591.238% |
| Orthofix Medical Inc. | -139.11 Million USD | -140.433% |
| Venus Concept Inc. | -28.3 Million USD | -1081.486% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | -519.062% |
| Bioventus Inc. | -81.72 Million USD | -309.259% |
| BrainsWay Ltd. | -4.92 Million USD | -6688.451% |
| Envoy Medical, Inc. | -18.37 Million USD | -1720.625% |
| electroCore, Inc. | -18.8 Million USD | -1678.607% |
| IceCure Medical Ltd | -15.57 Million USD | -2047.323% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -589.879% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -1836.915% |
| MaxCyte, Inc. | -48.29 Million USD | -592.493% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -2697.658% |
| Nexalin Technology, Inc. | -5.69 Million USD | -5771.658% |
| PAVmed Inc | -68.79 Million USD | -386.179% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | -491.318% |
| RxSight, Inc. | -50.08 Million USD | -567.799% |
| Sight Sciences, Inc. | -57.27 Million USD | -483.977% |
| SI-BONE, Inc. | -46.93 Million USD | -612.678% |
| TELA Bio, Inc. | -44.07 Million USD | -658.859% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | -517.668% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -550.36% |
| LivaNova PLC | -68.49 Million USD | -388.287% |
| 908 Devices Inc. | -42.75 Million USD | -682.233% |
| Alphatec Holdings, Inc. | -173.39 Million USD | -92.893% |
| Nemaura Medical Inc. | -9.59 Million USD | -3385.762% |
| NeuroPace, Inc. | -27.17 Million USD | -1130.835% |
| LENSAR, Inc. | -12.22 Million USD | -2635.031% |
| Apyx Medical Corporation | -17.25 Million USD | -1837.928% |
| Cutera, Inc. | -156.23 Million USD | -114.086% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -3787.343% |
| BioSig Technologies, Inc. | -28.51 Million USD | -1073.074% |
| Anika Therapeutics, Inc. | -87.63 Million USD | -281.642% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -1390.096% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 399.9% |
| Axonics, Inc. | -26.05 Million USD | -1183.597% |
| Outset Medical, Inc. | -169.77 Million USD | -97.012% |
| IRIDEX Corporation | -10 Million USD | -3242.33% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | -206.373% |
| IRadimed Corporation | 20.03 Million USD | 1769.375% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -3956.604% |
| INVO Bioscience, Inc. | -6.76 Million USD | -4842.505% |
| Telesis Bio, Inc. | -35.15 Million USD | -851.542% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 2434.033% |
| Varex Imaging Corporation | 32.1 Million USD | 1141.953% |
| Quipt Home Medical Corp. | 3.91 Million USD | 8634.499% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -2656.672% |
| Pulmonx Corporation | -61.93 Million USD | -440.029% |
| Dynatronics Corporation | -2.27 Million USD | -14614.471% |
| Modular Medical, Inc. | -17.52 Million USD | -1808.078% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -2184.767% |
| Semler Scientific, Inc. | 22.25 Million USD | 1602.817% |
| InMode Ltd. | 195.66 Million USD | 270.943% |
| Bruker Corporation | 436.9 Million USD | 176.555% |
| Cytosorbents Corporation | -31.2 Million USD | -971.692% |
| DexCom, Inc. | 597.7 Million USD | 155.959% |
| Align Technology, Inc. | 643.33 Million USD | 151.989% |
| Viveve Medical, Inc. | -21.55 Million USD | -1451.835% |
| ZimVie Inc. | -30.93 Million USD | -981.053% |
| Movano Inc. | -29.69 Million USD | -1026.531% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -1101.174% |
| Nexalin Technology, Inc. | -5.69 Million USD | -5771.658% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -9380.357% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | -43.407% |
| Profound Medical Corp. | -28.61 Million USD | -1068.811% |
| Insulet Corporation | 220 Million USD | 252.03% |
| enVVeno Medical Corporation | -25.23 Million USD | -1225.252% |
| Surmodics, Inc. | -5.64 Million USD | -5825.013% |
| iCAD, Inc. | -7.68 Million USD | -4249.941% |
| Nuwellis, Inc. | -17.63 Million USD | -1797.147% |
| Biotricity, Inc. | -8.82 Million USD | -3688.591% |
| iRhythm Technologies, Inc. | -125.16 Million USD | -167.229% |
| Aethlon Medical, Inc. | -12.63 Million USD | -2546.818% |
| InspireMD, Inc. | -21.14 Million USD | -1481.928% |
| PAVmed Inc. | -68.79 Million USD | -386.179% |
| BIOLASE, Inc. | -17.93 Million USD | -1764.676% |
| Beyond Air, Inc. | -63 Million USD | -430.849% |
| FONAR Corporation | 16.53 Million USD | 2122.737% |
| AxoGen, Inc. | -21.46 Million USD | -1458.415% |
| Vivani Medical, Inc. | -26.96 Million USD | -1140.375% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 1953.927% |
| Inari Medical, Inc. | -14.03 Million USD | -2283.602% |
| UFP Technologies, Inc. | 57.66 Million USD | 680.027% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -6687.625% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -5204.142% |
| Tenon Medical, Inc. | -15.72 Million USD | -2026.706% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -4375.074% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -683.181% |
| AdaptHealth Corp. | -598.4 Million USD | 44.107% |
| Sintx Technologies, Inc. | -13.35 Million USD | -2403.87% |
| NanoVibronix, Inc. | -3.43 Million USD | -9634.197% |
| Quanterix Corporation | -49.7 Million USD | -572.958% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -2656.672% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -87456.806% |
| TransMedics Group, Inc. | -28.72 Million USD | -1064.295% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -1316.513% |
| NeuroMetrix, Inc. | -7.15 Million USD | -4576.865% |
| Hyperfine, Inc. | -48.11 Million USD | -595.141% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | -414.359% |
| Biomerica, Inc. | -6.36 Million USD | -5153.133% |
| Bone Biologics Corporation | -9.42 Million USD | -3447.478% |
| AVITA Medical, Inc. | -40.4 Million USD | -727.846% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -3143.72% |
| Silk Road Medical, Inc | -59.27 Million USD | -464.301% |